To explore the effect of combination CXCR4/TRAIL/carboplatin treatment for brain metastasis of breast cancer, this study examined the anti-tumor effect of ExoCXCR4+TRAIL combined with carboplatin in an MDA-MB-231Br severe combined immunodeficiency (SCID) mouse model. This evidence concerns the gene TNFSF10 and breast carcinoma.